P.L. Dorn

671 total citations
18 papers, 447 citations indexed

About

P.L. Dorn is a scholar working on Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P.L. Dorn has authored 18 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 7 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P.L. Dorn's work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (7 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). P.L. Dorn is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (7 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). P.L. Dorn collaborates with scholars based in United States, United Kingdom and Canada. P.L. Dorn's co-authors include Claire Buchanan, Yasmin Hasan, Steven J. Chmura, Kimberly J. Van Zee, Patrick I. Borgen, Elizabeth A. Morris, Colleen Murphy, Loren K. Mell, S. Diane Yamada and Sonali Rudra and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

P.L. Dorn

18 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.L. Dorn United States 8 189 163 129 127 126 18 447
Mathieu Minsat France 12 156 0.8× 142 0.9× 72 0.6× 196 1.5× 73 0.6× 31 454
Louis Bazire France 9 131 0.7× 123 0.8× 71 0.6× 92 0.7× 60 0.5× 24 344
Kanjana Shotelersuk Thailand 10 151 0.8× 174 1.1× 44 0.3× 136 1.1× 50 0.4× 32 520
Gilles Houvenæghel France 13 161 0.9× 237 1.5× 75 0.6× 214 1.7× 62 0.5× 31 520
Georgina Fröhlich Hungary 12 207 1.1× 70 0.4× 121 0.9× 135 1.1× 77 0.6× 56 446
S. Heymann France 12 236 1.2× 178 1.1× 83 0.6× 71 0.6× 81 0.6× 33 450
F Volterrani Italy 7 294 1.6× 194 1.2× 195 1.5× 278 2.2× 42 0.3× 42 636
Piotr Skotnicki Poland 12 98 0.5× 135 0.8× 108 0.8× 80 0.6× 27 0.2× 31 392
Adam Dickler United States 17 404 2.1× 80 0.5× 128 1.0× 190 1.5× 181 1.4× 46 702
William W. Thoms United States 8 79 0.4× 131 0.8× 58 0.4× 140 1.1× 27 0.2× 14 365

Countries citing papers authored by P.L. Dorn

Since Specialization
Citations

This map shows the geographic impact of P.L. Dorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.L. Dorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.L. Dorn more than expected).

Fields of papers citing papers by P.L. Dorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.L. Dorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.L. Dorn. The network helps show where P.L. Dorn may publish in the future.

Co-authorship network of co-authors of P.L. Dorn

This figure shows the co-authorship network connecting the top 25 collaborators of P.L. Dorn. A scholar is included among the top collaborators of P.L. Dorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.L. Dorn. P.L. Dorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Toesca, Diego A.S., William F. Hartsell, T.A. DeWees, et al.. (2024). Stereotactic Body Proton Therapy Versus Conventionally Fractionated Proton Therapy for Early Prostate Cancer: A Randomized, Controlled, Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. 120(5). 1377–1385. 2 indexed citations
2.
Toesca, Diego A.S., William F. Hartsell, T.A. DeWees, et al.. (2023). Final Analysis of a Phase III Controlled Randomized Study of Stereotactic Body Proton Therapy or Conventionally Fractionated Proton Therapy for Early Prostate Cancer: PCG GU002. International Journal of Radiation Oncology*Biology*Physics. 117(2). S24–S25. 2 indexed citations
3.
4.
Holt, Douglas E., Susan M. Hiniker, John A. Kalapurakal, et al.. (2020). Improving the Pediatric Patient Experience During Radiation Therapy – A Children’s Oncology Group Study. International Journal of Radiation Oncology*Biology*Physics. 108(3). e216–e216. 1 indexed citations
5.
6.
Corbin, Kimberly S., P.L. Dorn, Supriya Jain, et al.. (2013). Hypofractionated Radiotherapy Does Not Increase Acute Toxicity in Large-Breasted Women. American Journal of Clinical Oncology. 37(4). 322–326. 22 indexed citations
7.
Rudra, Sonali, Michael D. Hasselle, P.L. Dorn, et al.. (2012). The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy. Cancer. 119(2). 325–331. 114 indexed citations
8.
Dorn, P.L., et al.. (2012). A Prospective Study of the Utility of Magnetic Resonance Imaging in Determining Candidacy for Partial Breast Irradiation. International Journal of Radiation Oncology*Biology*Physics. 85(3). 615–622. 21 indexed citations
9.
Jain, Supriya, P.L. Dorn, Steven J. Chmura, Ralph R. Weichselbaum, & Yasmin Hasan. (2012). Incidence and implications of oligometastatic breast cancer.. Journal of Clinical Oncology. 30(15_suppl). e11512–e11512. 18 indexed citations
10.
Dorn, P.L., Kimberly S. Corbin, Hania Al‐Hallaq, Yasmin Hasan, & Steven J. Chmura. (2011). Feasibility and Acute Toxicity of Hypofractionated Radiation in Large-breasted Patients. International Journal of Radiation Oncology*Biology*Physics. 83(1). 79–83. 25 indexed citations
11.
Dorn, P.L., et al.. (2011). Patterns of Distant Failure and Progression in Breast Cancer: Implications for the Treatment of Oligometastatic Disease. International Journal of Radiation Oncology*Biology*Physics. 81(2). S643–S643. 19 indexed citations
12.
Dorn, P.L. & Steven J. Chmura. (2011). Effect of Radiotherapy Boost and Hypofractionation on Outcomes in Ductal Carcinoma In Situ. Yearbook of Oncology. 2011. 52–54. 1 indexed citations
13.
Dorn, P.L., et al.. (2011). Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease. Breast Diseases A Year Book Quarterly. 22(2). 202–204. 1 indexed citations
14.
Dorn, P.L. & Steven J. Chmura. (2011). Effect of Radiotherapy Boost and Hypofractionation on Outcomes in Ductal Carcinoma In Situ. Breast Diseases A Year Book Quarterly. 22(3). 278–279. 4 indexed citations
15.
Dorn, P.L., et al.. (2010). Initial Report of UCCRC 3443: A Prospective Study on the Utility of Magnetic Resonance Imaging (MRI) in Determining Candidacy for Partial Breast Irradiation (PBI). International Journal of Radiation Oncology*Biology*Physics. 78(3). S3–S3. 3 indexed citations
16.
Buchanan, Claire, P.L. Dorn, Jane V. Fey, et al.. (2006). Locoregional Recurrence after Mastectomy: Incidence and Outcomes. Journal of the American College of Surgeons. 203(4). 469–474. 107 indexed citations
17.
Buchanan, Claire, Elizabeth A. Morris, P.L. Dorn, Patrick I. Borgen, & Kimberly J. Van Zee. (2005). Utility of Breast Magnetic Resonance Imaging in Patients With Occult Primary Breast Cancer. Annals of Surgical Oncology. 12(12). 1045–1053. 96 indexed citations
18.
Dahme, E., et al.. (1965). [On the problem of endocarditis in poultry. I. Types of endocarditis and their incidence].. PubMed. 78(12). 222–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mathieu Minsat Breakdown of academic impact, for papers by Louis Bazire Breakdown of academic impact, for papers by Kanjana Shotelersuk Breakdown of academic impact, for papers by Gilles Houvenæghel Breakdown of academic impact, for papers by Georgina Fröhlich Breakdown of academic impact, for papers by S. Heymann Breakdown of academic impact, for papers by F Volterrani Breakdown of academic impact, for papers by Piotr Skotnicki Breakdown of academic impact, for papers by Adam Dickler Breakdown of academic impact, for papers by William W. Thoms
Rankless by CCL
2026